US FDA’s First OTC Monograph Program User Fee Schedule Delayed For HHS Secretary’s Signature
Questions On Firms Subject To Fees Surfaced Immediately After Publication
Executive Summary
Rates published in December for FY2021 monograph user fee program prompted immediate questions and opposition. HHS says fee schedule is being withdrawn because the document “was issued without approval of the Secretary.”